World‑Renowned Dalhousie Bioethicist and Battery Pioneer Win Prestigious Killam Prize
By Andrew Riley and Caitlyn MacDonald,
Dal News
| 03. 15. 2022
Françoise Baylis, photo by XhenetaM,
CC BY-SA 4.0, via Wikimedia Commons
Two of Dalhousie’s leading researchers are being honoured with the $100,000 Killam Prize, winning two of the five prestigious awards granted annually by the Killam Trusts.
On Tuesday morning, the Canada Council for the Arts announced Françoise Baylis and Jeff Dahn as 2022 recipients of the honour. Offered to Canadian scholars who have distinguished themselves through sustained distinction and impact in their fields, the Killam Prize is considered the top national award of research excellence.
“It is a historic achievement for our university to have two Killam Prize winners in one year. Drs. Baylis and Dahn are known internationally for advancing knowledge in their fields – areas that promise to shape the way we live in the future,” says Deep Saini, Dalhousie’s president and vice-chancellor.
Drs. Baylis and Dahn are only the fifth and sixth Dalhousie faculty members to receive a Killam Prize since the awards were created in 1981. Biology’s Brian Hall (2005), Philosophy’s Susan Sherwin (2006), Chemistry's Axel Becke (2016), and Medicine's Ford Doolittle (2017)...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah A. Topol, The New York Times Magazine | 12.14.2025
The women in House 3 rarely had a chance to speak to the women in House 5, but when they did, the things they heard scared them. They didn’t actually know where House 5 was, only that it was huge...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
